Is Xtant Medical Holdings Stock a good buy in 2024, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NYSEMKT: XTNT) stock is to Strong Buy XTNT stock.
Out of 1 analyst, 1 (100%) are recommending XTNT as a Strong Buy, 0 (0%) are recommending XTNT as a Buy, 0 (0%) are recommending XTNT as a Hold, 0 (0%) are recommending XTNT as a Sell, and 0 (0%) are recommending XTNT as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year XTNT price target, the average XTNT price target is $2.00, with the highest XTNT stock price forecast at $2.00 and the lowest XTNT stock price forecast at $2.00.
The Wall Street analyst predicted that Xtant Medical Holdings's share price could reach $2.00 by Dec 5, 2024. The average Xtant Medical Holdings stock price prediction forecasts a potential upside of 120.02% from the current XTNT share price of $0.91.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.